MTNB (Matinas BioPharma Holdings, Inc.) Stock Analysis - SEC Filings

Matinas BioPharma Holdings, Inc. (MTNB) is a publicly traded Healthcare sector company. As of May 21, 2026, MTNB trades at $0.64 with a market cap of $3.46M and a P/E ratio of -0.30. MTNB moved +14.52% today. Year to date, MTNB is -0.64%; over the trailing twelve months it is -16.08%. Its 52-week range spans $0.47 to $4.25. Rallies surfaces MTNB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find MTNB SEC filings?

Rallies organizes MTNB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

MTNB Key Metrics

Key financial metrics for MTNB
MetricValue
Price$0.64
Market Cap$3.46M
P/E Ratio-0.30
EPS$-2.00
Dividend Yield0.00%
52-Week High$4.25
52-Week Low$0.47
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-10.35M
Gross Margin0.00%

Latest MTNB News

MTNB Analyst Consensus

MTNB analyst coverage data. Average price target: $0.00.

Common questions about MTNB

Where can I find MTNB SEC filings?
Rallies organizes MTNB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show MTNB 10-K and 10-Q filings?
Rallies organizes MTNB SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is MTNB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MTNB. It does not provide personalized investment advice.
MTNB

MTNB